| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rong-Jing Guo, Ting Gao, Zhe Ruan, Hong-Yu Zhou, Feng Gao, Quan Xu, Li-Ping Yu, Song-Di Wu, Tao Lei, Huan-Huan Li, Chao Sun, Min Zhang, Yan-Wu Gao, Xiao-Dan Lu, Yong-Lan Tang, Bao-Li Tang, Fei-Yan Huo, Ying Zhu, Zhu-Yi Li, Ting Chan. Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study. Neurology and therapy. 2021-11-03. PMID:34729706. |
many patients with ocular myasthenia gravis (omg) progress to generalized disease within the first 2 years of the onset of ocular symptoms. |
2021-11-03 |
2023-08-13 |
Not clear |
| Parinee Kemchoknatee, Apisama Arepagorn, Thansit Srisombu. Ocular manifestation and generalization after ocular onset in ocular myasthenia gravis: A 5-year analysis. Asian Pacific journal of allergy and immunology. 2021-10-31. PMID:34717528. |
ocular myasthenia gravis (omg) is an autoimmune disease which causes ptosis, diplopia, or both. |
2021-10-31 |
2023-08-13 |
Not clear |
| Gary R Cutter, Donald B Sander. If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it? Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2021-10-15. PMID:34651292. |
report a large retrospective study of the beneficial effects of thymectomy on the progression of ocular myasthenia gravis (omg) to generalized mg (gmg) (huanhuan et al. |
2021-10-15 |
2023-08-13 |
Not clear |
| Georgios Velonakis, Vassilis E Papadopoulos, Efstratios Karavasilis, Dimitrios K Filippiadis, Vasiliki Zouvelo. MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis. Neuroradiology. vol 63. issue 9. 2021-09-29. PMID:34232334. |
the aim of the study was to evaluate extraocular muscle (eom) atrophy and fatty replacement in ocular myasthenia gravis (omg) and generalized myasthenia gravis (gmg) patients with chronic and untreated ocular symptoms or with inadequate response to immunotherapy and unprovoked ocular exacerbations despite chronic immunotherapy. |
2021-09-29 |
2023-08-13 |
Not clear |
| Kristen S Fisher, Jason Gill, Hannah F Todd, Michael B Yang, Michael A Lopez, Farida Abid, Timothy Lotze, Veeral S Sha. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort. Pediatric neurology. vol 118. 2021-09-20. PMID:33684630. |
ocular myasthenia gravis (omg) is localized, affecting only extraocular and/or levator palpebrae muscles. |
2021-09-20 |
2023-08-13 |
Not clear |
| Yoshihiko Isshiki, Osamu Mimura, Fumi Gom. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis. Japanese journal of ophthalmology. vol 64. issue 6. 2021-08-18. PMID:32936398. |
to clarify the factors predictive of progression from ocular myasthenia gravis (omg) to generalized mg (gmg) among patients with positive antiacetylcholine receptor antibodies (achrab) and to evaluate the efficacy of our omg treatment protocol including tacrolimus (tac). |
2021-08-18 |
2023-08-13 |
Not clear |
| Hyuna Kim, Shin Yeop O. Diagnostic yields and clinical features of ocular myasthenia gravis. Medicine. vol 100. issue 25. 2021-06-29. PMID:34160444. |
to investigate clinical features and diagnosis process of ocular myasthenia gravis (omg) in ophthalmology department.a total of 36 patients with ptosis or diplopia who had follow-up for at least 3 months between march 2016 and december 2019 were included in this study. |
2021-06-29 |
2023-08-13 |
Not clear |
| Juthamat Witthayaweerasak, Narisa Rattanalert, Nipat Aui-Are. Prognostic factors for conversion to generalization in ocular myasthenia gravis. Medicine. vol 100. issue 19. 2021-06-22. PMID:34106649. |
patients with ocular myasthenia gravis (omg) are frequently treated to prevent the development of generalized myasthenia gravis (gmg). |
2021-06-22 |
2023-08-13 |
Not clear |
| Feng Li, Zhongmin Li, Yanli Chen, Gero Bauer, Deniz Uluk, Aron Elsner, Marc Swierzy, Mahmoud Ismail, Andreas Meisel, Jens-C Rücker. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. vol 57. issue 3. 2021-06-21. PMID:31628812. |
this study aimed to compare the outcomes of patients with ocular myasthenia gravis (omg) who underwent thymectomy before generalization with the outcomes of those who underwent thymectomy after generalization. |
2021-06-21 |
2023-08-13 |
Not clear |
| Benjamin Claytor, Yuebing L. Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease. Muscle & nerve. vol 63. issue 5. 2021-06-10. PMID:33247453. |
ocular myasthenia gravis (omg) and thyroid eye disease are two autoimmune conditions that have several overlapping clinical features, and these coexist with a small but not insignificant frequency. |
2021-06-10 |
2023-08-13 |
Not clear |
| Ali G Hamedani, Maxwell Pistilli, Sunil Singhal, Kenneth S Shindler, Robert A Avery, Madhura A Tamhankar, Grant T Li. Outcomes After Transcervical Thymectomy for Ocular Myasthenia Gravis: A Retrospective Cohort Study With Inverse Probability Weighting. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. vol 40. issue 1. 2021-05-28. PMID:31453917. |
it is unclear whether this benefit applies to patients with myasthenia and purely ocular manifestations (ocular myasthenia gravis [omg]). |
2021-05-28 |
2023-08-13 |
Not clear |
| Minghua Shi, Yingjia Ye, Junping Zhou, Aijiao Qin, Jing Cheng, Hongxing Re. Local use of dexamethasone in the treatment of ocular myasthenia gravis. BMC ophthalmology. vol 20. issue 1. 2021-05-14. PMID:33115419. |
at present, patients with ocular myasthenia gravis (omg) are typically treated with systemic drugs. |
2021-05-14 |
2023-08-13 |
Not clear |
| Rashmi Verma, Gil I Wolfe, Mark J Kupersmit. Ocular myasthenia gravis - How effective is low dose prednisone long term? Journal of the neurological sciences. vol 420. 2021-05-14. PMID:33360170. |
controversy persists on the best treatment to control ocular myasthenia gravis (omg) and reduce conversion to generalized myasthenia gravis (gmg). |
2021-05-14 |
2023-08-13 |
Not clear |
| Na Wu, Erdem Tüzün, Yi Cheng, Li Yan, Yajun Wu, Jie Rao, Hui Huang, Siyu Li, Ling Shi, Xiaorong W. Central Role of T Follicular Helper Cells in Myasthenia Gravis. Noro psikiyatri arsivi. vol 58. issue 1. 2021-04-03. PMID:33795956. |
ocular myasthenia gravis (omg) is often the initial manifestation of mg and has the potential to progress to gmg. |
2021-04-03 |
2023-08-13 |
Not clear |
| Ruiqi Ma, Yun Cheng, Lu Gan, Xiaoting Zhou, Jiang Qia. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report. BMC ophthalmology. vol 20. issue 1. 2021-03-17. PMID:32321476. |
coexistence of thyroid-associated ophthalmopathy (tao) and ocular myasthenia gravis (omg) is very rare. |
2021-03-17 |
2023-08-13 |
Not clear |
| Akiko Nagaishi, Tomoko Narita, Mark Woodhall, Leslie Jacobson, Patrick Waters, Sarosh R Irani, Angela Vincent, Hidenori Matsu. Autoantibodies in Japanese patients with ocular myasthenia gravis. Muscle & nerve. vol 63. issue 2. 2021-03-15. PMID:33094484. |
the majority of patients with myasthenia gravis (mg) initially present with ocular symptoms, but it is difficult to predict which cases will remain as ocular mg (omg) or will progress to generalized mg. herein we evaluated the serologic profile of japanese omg and its relationship with clinical features. |
2021-03-15 |
2023-08-13 |
Not clear |
| Ayşın Kısabay, Hüseyin Nezih Özdemir, Figen Gökçay, Neşe Çelebiso. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic. Acta neurologica Belgica. 2021-02-05. PMID:33544334. |
conversion to generalized myasthenia gravis (gmg) within the first 2 years has been reported in 18-85% of patients with ocular myasthenia gravis (omg). |
2021-02-05 |
2023-08-13 |
Not clear |
| Ayşın Kısabay, Hüseyin Nezih Özdemir, Figen Gökçay, Neşe Çelebiso. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic. Acta neurologica Belgica. 2021-02-05. PMID:33544334. |
the aim of the study was to investigate the risk factors for generalization in patients with omg admitted to a neuro-ophthalmology clinic and to determine if there were differences between patients with gmg with predominant bulbar (gmg-b) or extremity muscle (gmg-e) involvement according to the 6th and 24th-month myasthenia gravis foundation of america classification ranks. |
2021-02-05 |
2023-08-13 |
Not clear |
| Andrew T Melson, Collin M McClelland, Michael S Le. Ocular myasthenia gravis: updates on an elusive target. Current opinion in neurology. vol 33. issue 1. 2021-01-22. PMID:31789705. |
ocular myasthenia gravis (omg) is a complex condition with heterogenous phenotypes and ill-defined diagnostic criteria. |
2021-01-22 |
2023-08-13 |
Not clear |
| Amelia Evoli, Raffaele Iori. Controversies in Ocular Myasthenia Gravis. Frontiers in neurology. vol 11. 2020-12-18. PMID:33329368. |
myasthenia gravis (mg) with symptoms limited to eye muscles [ocular mg (omg)] is a rare disease. |
2020-12-18 |
2023-08-13 |
Not clear |